Our guiding purpose
SynOx Therapeutics was founded with a clear purpose: to improve the lives of people living with TGCT. We believe that although TGCT is a rare condition, the people affected by it deserve the same commitment to innovation, research and support as anyone living with a more common disease.
Behind every TGCT diagnosis is a person whose daily life has changed. Living with pain, reduced mobility and uncertainty can affect far more than a joint – it can affect work, family life, independence and confidence. Those experiences help shape the science we pursue and the decisions we make every day.
As a biotechnology company focused on macrophage biology, we’re working to develop new treatment options for people living with TGCT and to advance understanding of this rare disease.
Our values
Patient first
We place patients at the heart of every decision. We listen to the science, the data and the lived experience of those affected by rare disease – ensuring our work always connects back to real human lives.
COURAGE TO INNOVATE
We are brave in our thinking and bold in action. We challenge assumptions, explore new ideas and make thoughtful decisions – knowing progress requires curiosity and resilience.
ONE TEAM, ONE PURPOSE
We work as one team – across
functions, geographies, and with our partners. We share openly, support each other, and succeed together. When we collaborate, our impact is stronger.
ADAPTIVE AND AGILE
We stay flexible and responsive as our science evolves. We adapt quickly, make thoughtful decisions, and continuously refine our approach as we learn.
INTEGRITY IN EVERYTHING
We act ethically, transparently, and with honesty. We follow the data and hold ourselves accountable to the highest scientific and professional standards.
Sarah Clare
SVP Finance & Operations
Building a great company is about more than advancing great science. It means creating a culture where talented people can do their best work, supported by the right systems, ways of working and shared values. When those foundations are strong, people can stay focused on what matters most – working together to improve the lives of people living with rare diseases.
Investors
SynOx is backed by a world-class group of life science investors who share our commitment to improving outcomes for people living with rare diseases.
